Fulltext

Value of a specific bradycardic agent in cardiac surgery compared to placebo

Skarvan, K.

In: European Heart Journal, 1987, vol. 8, p. 123-129

Add to personal list
    Title
    • Value of a specific bradycardic agent in cardiac surgery compared to placebo
    Author
    • Skarvan, K.. Department of Anesthesia, University of Basell Kantonsspit, CH-4031 Basel, Switzerland
    Document Type
    • Postprint
    OAI-PMH Identifier
    • oai:doc.rero.ch:297306
    Summary
    The effects of alinidine on systemic and pulmonary haemodynamics and the ECG were studied in 8 patients early after open heart surgery as a double-blind cross-over comparison between alinidine and placebo. Placebo had no effect on any of the measured variables. Alinidine given as an i.v. bolus (10 mg) followed by an infusion (10 mg h−1) was associated with alinidine plasma levels of 172 ± 17 and 114 ± 13, respectively, (±SE, ng ml−1) and decreased heart rate (−12%) and rate-pressure product (−14%) in all patients. While stroke volume index tended to increase, there were no changes in arterial, pulmonary and atrial pressures, cardiac index, and systemic and pulmonary vascular resistances. PR and QRS intervals of the ECG remained unaffected, and the QTC interval transiently decreased. Alinidine appears to be a suitable drug for control of inappropriate sinus tachycardia in patients with heart disease undergoing surgery